Group One Trading’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,510
| Closed | -$7.57K | – | 8195 |
|
|
2024
Q3 | $7.57K | Sell |
1,510
-10,080
| -87% | -$65.4K | ﹤0.01% | 5726 |
|
|
2024
Q2 | $76.5K | Sell |
11,590
-28,150
| -71% | -$191K | ﹤0.01% | 4170 |
|
|
2024
Q1 | $437K | Sell |
39,740
-43,070
| -52% | -$466K | ﹤0.01% | 2872 |
|
|
2023
Q4 | $1.12M | Buy |
82,810
+36,730
| +80% | +$595K | ﹤0.01% | 2369 |
|
|
2023
Q3 | $1,000K | Sell |
46,080
-20
| -0% | -$641 | ﹤0.01% | 2270 |
|
|
2023
Q2 | $1.77M | Buy |
46,100
+1,240
| +3% | +$43.7K | 0.01% | 1817 |
|
|
2023
Q1 | $1.24M | Buy |
44,860
+42,847
| +2,129% | +$1.45M | ﹤0.01% | 1947 |
|
|
2022
Q4 | $66.3K | Sell |
2,013
-335
| -14% | -$24.4K | ﹤0.01% | 4787 |
|
|
2022
Q3 | $285K | Sell |
2,348
-610
| -21% | -$110K | ﹤0.01% | 3799 |
|
|
2022
Q2 | $518K | Sell |
2,958
-2,340
| -44% | -$493K | ﹤0.01% | 3387 |
|
|
2022
Q1 | $1.54M | Sell |
5,298
-9,749
| -65% | -$3.7M | ﹤0.01% | 2668 |
|
|
2021
Q4 | $7.86M | Buy |
15,047
+7,969
| +113% | +$5.72M | 0.01% | 1305 |
|
|
2021
Q3 | $2.69M | Buy |
7,078
+6,943
| +5,143% | +$2.98M | ﹤0.01% | 2351 |
|
|
2021
Q2 | $120K | Buy |
135
+106
| +366% | +$81.1K | ﹤0.01% | 5785 |
|
|
2021
Q1 | $35K | Buy |
+29
| New | +$40K | ﹤0.01% | 6459 |
|
Group One Trading's BIOR Position: Q4 2023 in Review
Group One Trading sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2023, closing a stake of 470 shares — an estimated $7.62K sold.
Group One Trading first reported a position in BIOR in Q1 2021 and held it in 9 quarters. The position peaked at $129K in Q3 2021. 29 funds tracked by Wall St. Rank hold BIOR as of Q4 2023.
- Group One Trading reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Group One Trading sold 470 Biora Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $7.62K.
- Group One Trading first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
- Group One Trading's Biora Therapeutics, Inc. Common Stock position peaked at $129K in Q3 2021.
- 29 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2023.
Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.